2018
DOI: 10.1016/j.actbio.2017.12.014
|View full text |Cite
|
Sign up to set email alerts
|

Antioxidant functionalized polymer capsules to prevent oxidative stress

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
53
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 58 publications
(53 citation statements)
references
References 86 publications
0
53
0
Order By: Relevance
“…A wide variety of enzymatic reactions have been performed in the polymer capsules. The PAH/DS/TA microcapsules exhibited an excellent scavenging capacity for hydrogen peroxide and hydroxyl radical, suggesting better antioxidant properties [188]. Catalase enzyme encapsulated in the capsules was used to prevent oxidative stress in an in vitro inflammation model depicting that the PE shell can make encapsulated enzymes more stable compared to free enzymes.…”
Section: Bioreactorsmentioning
confidence: 99%
“…A wide variety of enzymatic reactions have been performed in the polymer capsules. The PAH/DS/TA microcapsules exhibited an excellent scavenging capacity for hydrogen peroxide and hydroxyl radical, suggesting better antioxidant properties [188]. Catalase enzyme encapsulated in the capsules was used to prevent oxidative stress in an in vitro inflammation model depicting that the PE shell can make encapsulated enzymes more stable compared to free enzymes.…”
Section: Bioreactorsmentioning
confidence: 99%
“…Reports to date include the encapsulation of antioxidant enzymes within several carriers including liposomes, 10 polymersomes, 11 polymer capsules 12 or mesoporous silica particles. 13 While these encapsulation platforms have successfully demonstrated the ability to sustain enzymatic reactions, even within the complex intracellular environment, [11][12][13] it is worth noticing that such architectures are typically fabricated by a single constituent material (i.e., lipids, polymers or silica). However, hybrid architectures composed of two different types of materials have emerged as an interesting alternative.…”
Section: Introductionmentioning
confidence: 99%
“…The main limitations of small molecule antioxidants lie in their systemic distribution, rapid metabolism, and low retention at the diseased site, thereby resulting in low bioavailability in target tissues/cells. In this aspect, nanoparticles can protect the loaded small molecule antioxidants from hydrolysis, achieve site-specific delivery and controlled release of antioxidants at disease sites, and therefore improve their bioavailability ( Table 3) (Wang et al, 2015;Kang et al, 2016;Jung et al, 2018;Larrañaga et al, 2018;Gou et al, 2019). For example, our group fabricated a SOD/CAT-mimetic nanomedicine comprising H 2 O 2 -eliminating nanoparticles derived from a PBAP-conjugated β-CD material and a free radical scavenger Tempol .…”
Section: Drug-loaded Nanoparticles With Antioxidant Activitymentioning
confidence: 99%